FGF23 and COVID-19: Concerning additional baseline variables before the SARS-CoV-2 infection, the only parameter which differed between both groups was plasma FGF23 which was higher in those who developed COVID-19 (436 [269–669] vs. 288 [195–580] pg/mL, p = 0.026).